UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 204

Sortiert nach

Incidence of fistula occurrence in patients with cervical cancer treated with bevacizumab: data from real-world clinical practice

International journal of clinical oncology, 2022-09, Vol.27 (9), p.1517-1528

2022

Volltextzugriff (PDF)

Retroviral replicating vector-mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity

Neuro-oncology (Charlottesville, Va.), 2017-07, Vol.19 (7), p.918-929

2017

Volltextzugriff (PDF)

Worsening of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio in patients with prostate cancer after androgen deprivation therapy

Asian journal of andrology, 2018-11, Vol.20 (6), p.634-636

2018

Volltextzugriff (PDF)

MicroRNA 142-3p attenuates spread of replicating retroviral vector in hematopoietic lineage-derived cells while maintaining an antiviral immune response

Human gene therapy, 2014-08, Vol.25 (8), p.759

2014

Volltextzugriff (PDF)

Incidence of gastrointestinal perforation associated with bevacizumab in combination with neoadjuvant chemotherapy as first-line treatment of advanced ovarian, fallopian tube, or peritoneal cancer: analysis of a Japanese healthcare claims database

Journal of gynecologic oncology, 2022-11, Vol.33 (6), p.1-14

2022

Volltextzugriff (PDF)

Incidence of gastrointestinal perforation associated with bevacizumab in combination with neoadjuvant chemotherapy as first-line treatment of advanced ovarian, fallopian tube, or peritoneal cancer: analysis of a Japanese healthcare claims database

Journal of gynecologic oncology, 2022-11, Vol.33 (6)

2022

Volltextzugriff (PDF)

STEM-24. THERAPEUTIC APPROACH OF STEM CELL CARRYING RETROVIRAL REPLICATING VECTORS IN HUMAN GLIOMA MODEL

Neuro-oncology (Charlottesville, Va.), 2019-11, Vol.21 (Supplement_6), p.vi238-vi239

2019

Volltextzugriff (PDF)

Abiraterone acetate as first-line treatment for CRPC

Annals of oncology, 2016-11, Vol.27, p.vii54

2016

Volltextzugriff (PDF)

Treatment strategy for prostate cancer patients with bone metastases

Annals of oncology, 2017-10, Vol.28, p.ix33-ix33

2017

Volltextzugriff (PDF)

TMOD-15. TOCA 511 & TOCA FC: PRE-CLINICAL PROOF OF CONCEPT IN CNS METASTATIC BREAST CANCER

Neuro-oncology (Charlottesville, Va.), 2017-11, Vol.19 (suppl_6), p.vi257-vi257

2017

Volltextzugriff (PDF)

433. Sequence-Optimized Nitroreductase for Retroviral Replicating Vector (RRV) Mediated Prodrug Activator Gene Therapy in Human Glioma Models

Molecular therapy, 2015-05, Vol.23, p.S171-S171

2015

Volltextzugriff (PDF)

629. Preclinical Evaluation of Prodrug Activator Gene Therapy by Retroviral Replicating Vectors (RRV) in Experimental Models of Breast Cancer CNS Metastasis

Molecular therapy, 2015-05, Vol.23, p.S250-S250

2015

Volltextzugriff (PDF)

Radiosensitization of gliomas by intracellular generation of 5-fluorouracil potentiates prodrug activator gene therapy with a retroviral replicating vector

Cancer gene therapy, 2014-10, Vol.21 (10), p.405-410

2014

Volltextzugriff (PDF)

ET-13RETROVIRAL REPLICATING VECTOR (RRV)-MEDIATED PRODRUG ACTIVATOR GENE THERAPY WITH CODON-OPTIMIZED NITROREDUCTASE IN EXPERIMENTAL GLIOMA

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (Suppl 5), p.v81-v82

2014

Volltextzugriff (PDF)

ET-23THERAPEUTIC EFFICACY OF RETROVIRAL REPLICATING VECTORS IN HUMAN BREAST CANCER CNS METASTASIS MODEL

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (Suppl 5), p.v84-v84

2014

Volltextzugriff (PDF)

ET-23 THERAPEUTIC EFFICACY OF RETROVIRAL REPLICATING VECTORS IN HUMAN BREAST CANCER CNS METASTASIS MODEL

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v84-v84

2014

Volltextzugriff (PDF)

328 PROSTATE-TARGETED RETROVIRAL REPLICATING VECTORS FOR PRODRUG-ACTIVATOR GENE THERAPY

The Journal of urology, 2013-04, Vol.189 (4), p.e133-e133

2013

Volltextzugriff (PDF)

ET-13 RETROVIRAL REPLICATING VECTOR (RRV)-MEDIATED PRODRUG ACTIVATOR GENE THERAPY WITH CODON-OPTIMIZED NITROREDUCTASE IN EXPERIMENTAL GLIOMA

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v81-v82

2014

Volltextzugriff (PDF)

IMPS-19RETROVIRAL REPLICATING VECTOR-MEDIATED DELIVERY OF AN IMMUNODOMINANT NEO-ANTIGEN EPITOPE TARGET FOR VIRO-IMMUNOTHERAPY IN EXPERIMENTAL GLIOMA

Neuro-oncology (Charlottesville, Va.), 2015-11, Vol.17 (suppl 5), p.v117.2-v117

2015

Volltextzugriff (PDF)

Combined Alloreactive CTL Cellular Therapy with Prodrug Activator Gene Therapy in a Model of Breast Cancer Metastatic to the Brain

Clinical cancer research, 2013-08, Vol.19 (15), p.4137-4148

2013

Volltextzugriff (PDF)

ET-60ENHANCED THERAPEUTIC EFFICACY OF PRODRUG ACTIVATOR GENE THERAPY WITH A NON-LYTIC RETROVIRAL REPLICATING VECTOR (TOCA 511) COMBINED WITH RADIATION THERAPY IN EXPERIMENTAL GLIOMA

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (Suppl 5), p.v92-v92

2014

Volltextzugriff (PDF)

Abstract 5397: Human mesenchymal stem cell-based cell carrier for tumor-homing delivery of replicating retrovirus vectors in glioblastoma models

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.5397-5397

2011

Volltextzugriff (PDF)

ET-60 ENHANCED THERAPEUTIC EFFICACY OF PRODRUG ACTIVATOR GENE THERAPY WITH A NON-LYTIC RETROVIRAL REPLICATING VECTOR (TOCA 511) COMBINED WITH RADIATION THERAPY IN EXPERIMENTAL GLIOMA

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v92-v92

2014

Volltextzugriff (PDF)

Radio-sensitization of gliomas by intracellular generation of 5-fluorouracil potentiates prodrug activator gene therapy with a retroviral replicating vector

Cancer gene therapy, 2014-10, Vol.21 (10), p.405-410

2014

Volltextzugriff (PDF)

Abstract 5393: Prodrug activator gene therapy mediated by prostate-specific replicating retrovirus vectors

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.5393-5393

2011

Volltextzugriff (PDF)

1 – 25 von 204

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(201)
Mit Volltextzugriff
(198)

Publikationsform

Artikel
(203)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(169)
Life Sciences & Biomedicine
(135)
Pregnancy
(121)
Humans
(81)
Female
(75)
Children
(67)
Questionnaires
(52)
Womens Health
(51)
Cohort Analysis
(46)
Japan
(46)
Japan - Epidemiology
(46)
Cohort Studies
(43)
Pediatrics
(39)
Risk Factors
(39)
Child
(38)
Adult
(36)
Multidisciplinary Sciences
(35)
Regression Analysis
(35)
Science & Technology - Other Topics
(35)
Pregnant Women
(33)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Incidence of fistula occurrence in patients with cervical cancer treated with bevacizumab: data from real-world clinical practice

Retroviral replicating vector-mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity

Worsening of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio in patients with prostate cancer after androgen deprivation therapy

MicroRNA 142-3p attenuates spread of replicating retroviral vector in hematopoietic lineage-derived cells while maintaining an antiviral immune response

Incidence of gastrointestinal perforation associated with bevacizumab in combination with neoadjuvant chemotherapy as first-line treatment of advanced ovarian, fallopian tube, or peritoneal cancer: analysis of a Japanese healthcare claims database

Incidence of gastrointestinal perforation associated with bevacizumab in combination with neoadjuvant chemotherapy as first-line treatment of advanced ovarian, fallopian tube, or peritoneal cancer: analysis of a Japanese healthcare claims database

STEM-24. THERAPEUTIC APPROACH OF STEM CELL CARRYING RETROVIRAL REPLICATING VECTORS IN HUMAN GLIOMA MODEL

Abiraterone acetate as first-line treatment for CRPC

Treatment strategy for prostate cancer patients with bone metastases

TMOD-15. TOCA 511 & TOCA FC: PRE-CLINICAL PROOF OF CONCEPT IN CNS METASTATIC BREAST CANCER

433. Sequence-Optimized Nitroreductase for Retroviral Replicating Vector (RRV) Mediated Prodrug Activator Gene Therapy in Human Glioma Models

629. Preclinical Evaluation of Prodrug Activator Gene Therapy by Retroviral Replicating Vectors (RRV) in Experimental Models of Breast Cancer CNS Metastasis

Radiosensitization of gliomas by intracellular generation of 5-fluorouracil potentiates prodrug activator gene therapy with a retroviral replicating vector

ET-13RETROVIRAL REPLICATING VECTOR (RRV)-MEDIATED PRODRUG ACTIVATOR GENE THERAPY WITH CODON-OPTIMIZED NITROREDUCTASE IN EXPERIMENTAL GLIOMA

ET-23THERAPEUTIC EFFICACY OF RETROVIRAL REPLICATING VECTORS IN HUMAN BREAST CANCER CNS METASTASIS MODEL

ET-23 THERAPEUTIC EFFICACY OF RETROVIRAL REPLICATING VECTORS IN HUMAN BREAST CANCER CNS METASTASIS MODEL

328 PROSTATE-TARGETED RETROVIRAL REPLICATING VECTORS FOR PRODRUG-ACTIVATOR GENE THERAPY

ET-13 RETROVIRAL REPLICATING VECTOR (RRV)-MEDIATED PRODRUG ACTIVATOR GENE THERAPY WITH CODON-OPTIMIZED NITROREDUCTASE IN EXPERIMENTAL GLIOMA

IMPS-19RETROVIRAL REPLICATING VECTOR-MEDIATED DELIVERY OF AN IMMUNODOMINANT NEO-ANTIGEN EPITOPE TARGET FOR VIRO-IMMUNOTHERAPY IN EXPERIMENTAL GLIOMA

Combined Alloreactive CTL Cellular Therapy with Prodrug Activator Gene Therapy in a Model of Breast Cancer Metastatic to the Brain

ET-60ENHANCED THERAPEUTIC EFFICACY OF PRODRUG ACTIVATOR GENE THERAPY WITH A NON-LYTIC RETROVIRAL REPLICATING VECTOR (TOCA 511) COMBINED WITH RADIATION THERAPY IN EXPERIMENTAL GLIOMA

Abstract 5397: Human mesenchymal stem cell-based cell carrier for tumor-homing delivery of replicating retrovirus vectors in glioblastoma models

ET-60 ENHANCED THERAPEUTIC EFFICACY OF PRODRUG ACTIVATOR GENE THERAPY WITH A NON-LYTIC RETROVIRAL REPLICATING VECTOR (TOCA 511) COMBINED WITH RADIATION THERAPY IN EXPERIMENTAL GLIOMA

Radio-sensitization of gliomas by intracellular generation of 5-fluorouracil potentiates prodrug activator gene therapy with a retroviral replicating vector

Abstract 5393: Prodrug activator gene therapy mediated by prostate-specific replicating retrovirus vectors

Aktive Filter

Suchergebnisse filtern